Thyroid function tests: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 11: | Line 11: | ||
TFTs may be requested if a patient is thought to suffer from [[hyperthyroidism]] (overactive thyroid) or [[hypothyroidism]] (underactive thyroid), or to monitor the effectiveness of either thyroid-suppression or hormone replacement therapy. It is also requested routinely in conditions linked to thyroid disease, such as [[atrial fibrillation]]. | TFTs may be requested if a patient is thought to suffer from [[hyperthyroidism]] (overactive thyroid) or [[hypothyroidism]] (underactive thyroid), or to monitor the effectiveness of either thyroid-suppression or hormone replacement therapy. It is also requested routinely in conditions linked to thyroid disease, such as [[atrial fibrillation]]. | ||
==Differential Diagnosis== | |||
===TSH levels increased=== | |||
*[[Mifepristone]] | |||
===TSH leves decreased=== | |||
[[Category:Chemical pathology]] | [[Category:Chemical pathology]] |
Revision as of 17:46, 22 December 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: TFTs
Overview
Thyroid function tests (TFTs) is a collective term for blood tests used to check the function of the thyroid.
A TFT panel typically includes thyroid-stimulating hormone (TSH, thyrotropin) and thyroxine (T4), and triiodothyronine (T3) depending on local laboratory policy.
TFTs may be requested if a patient is thought to suffer from hyperthyroidism (overactive thyroid) or hypothyroidism (underactive thyroid), or to monitor the effectiveness of either thyroid-suppression or hormone replacement therapy. It is also requested routinely in conditions linked to thyroid disease, such as atrial fibrillation.